HEADER TRANSFERASE 03-MAY-12 4AT3 TITLE CRYSTAL STRUCTURE OF TRKB KINASE DOMAIN IN COMPLEX WITH CPD5N COMPND MOL_ID: 1; COMPND 2 MOLECULE: BDNF/NT-3 GROWTH FACTORS RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN, RESIDUES 543-838; COMPND 5 SYNONYM: GP145-TRKB, TRK-B, NEUROTROPHIC TYROSINE KINASE RECEPTOR COMPND 6 TYPE 2, TRKB TYROSINE KINASE, TROPOMYOSIN-RELATED KINASE B; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR T.BERTRAND,M.KOTHE,J.LIU,A.DUPUY,A.RAK,P.F.BERNE,S.DAVIS, AUTHOR 2 T.GLADYSHEVA,C.VALTRE,J.Y.CRENNE,M.MATHIEU REVDAT 5 20-DEC-23 4AT3 1 REMARK REVDAT 4 24-APR-19 4AT3 1 SOURCE REVDAT 3 03-APR-19 4AT3 1 REMARK REVDAT 2 10-OCT-12 4AT3 1 JRNL REVDAT 1 22-AUG-12 4AT3 0 JRNL AUTH T.BERTRAND,M.KOTHE,J.LIU,A.DUPUY,A.RAK,P.F.BERNE,S.DAVIS, JRNL AUTH 2 T.GLADYSHEVA,C.VALTRE,J.Y.CRENNE,M.MATHIEU JRNL TITL THE CRYSTAL STRUCTURES OF TRKA AND TRKB SUGGEST KEY REGIONS JRNL TITL 2 FOR ACHIEVING SELECTIVE INHIBITION. JRNL REF J.MOL.BIOL. V. 423 439 2012 JRNL REFN ISSN 0022-2836 JRNL PMID 22902478 JRNL DOI 10.1016/J.JMB.2012.08.002 REMARK 2 REMARK 2 RESOLUTION. 1.77 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.9.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.77 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.87 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 36906 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.200 REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.224 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.960 REMARK 3 FREE R VALUE TEST SET COUNT : 3675 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 19 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.77 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.82 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.64 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2669 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2309 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2388 REMARK 3 BIN R VALUE (WORKING SET) : 0.2292 REMARK 3 BIN FREE R VALUE : 0.2451 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.53 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 281 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2331 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 24 REMARK 3 SOLVENT ATOMS : 315 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 23.04 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.78 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.54990 REMARK 3 B22 (A**2) : 1.03640 REMARK 3 B33 (A**2) : 0.51350 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.222 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.120 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.112 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.112 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.107 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.944 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.929 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2425 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3277 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 838 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 63 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 349 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2425 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 302 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2995 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 0.94 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.47 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.86 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: IDEAL-DIST CONTACT TERM CONTACT SETUP. REMARK 3 ALL ATOMS HAVE CCP4 ATOM TYPE FROM LIBRARY. REMARK 4 REMARK 4 4AT3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 03-MAY-12. REMARK 100 THE DEPOSITION ID IS D_1290052383. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-APR-08 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.933 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37068 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.770 REMARK 200 RESOLUTION RANGE LOW (A) : 47.190 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 4.100 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.77 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.81 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.8 REMARK 200 DATA REDUNDANCY IN SHELL : 2.80 REMARK 200 R MERGE FOR SHELL (I) : 0.33000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 4ASZ REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.83 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: THE TRKB-CPD5N COMPLEX WAS OBTAINED BY REMARK 280 COCRYSTALLIZATION IN 1.6 M AMMONIUM SULFATE, 50 MM MES, PH 6.0 REMARK 280 AT 4 DEGREESC IN PRESENCE OF 2 MM OF INHIBITOR., TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 43.16550 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 47.17000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 43.16550 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 47.17000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 578 REMARK 465 GLU A 579 REMARK 465 GLN A 580 REMARK 465 ASP A 581 REMARK 465 LYS A 591 REMARK 465 ASP A 592 REMARK 465 GLU A 657 REMARK 465 GLY A 658 REMARK 465 ASP A 716 REMARK 465 VAL A 717 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 NZ LYS A 567 O HOH A 2276 4444 0.21 REMARK 500 CE LYS A 567 O HOH A 2276 4444 1.30 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 594 142.58 -173.08 REMARK 500 ARG A 691 -14.53 78.79 REMARK 500 ASP A 692 43.46 -144.51 REMARK 500 ASP A 710 -62.99 72.78 REMARK 500 SER A 714 -132.78 61.14 REMARK 500 HIS A 728 -39.24 -130.01 REMARK 500 TYR A 833 -15.99 -143.56 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2271 DISTANCE = 5.85 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LTI A 1839 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1HCF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF TRKB-D5 BOUND TO NEUROTROPHIN-4/5 REMARK 900 RELATED ID: 1WWB RELATED DB: PDB REMARK 900 LIGAND BINDING DOMAIN OF HUMAN TRKB RECEPTOR REMARK 900 RELATED ID: 4ASZ RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURES OF TRKA AND TRKB SUGGEST KEY REGIONS FOR REMARK 900 ACHIEVING SELECTIVE INHIBITION REMARK 900 RELATED ID: 4AT4 RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURES OF TRKA AND TRKB SUGGEST KEY REGIONS FOR REMARK 900 ACHIEVING SELECTIVE INHIBITION REMARK 900 RELATED ID: 4AT5 RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURES OF TRKA AND TRKB SUGGEST KEY REGIONS FOR REMARK 900 ACHIEVING SELECTIVE INHIBITION REMARK 900 RELATED ID: 4F0I RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF APO TRKA DBREF 4AT3 A 543 838 UNP Q16620 NTRK2_HUMAN 543 838 SEQADV 4AT3 GLY A 1 UNP Q16620 EXPRESSION TAG SEQADV 4AT3 ALA A 2 UNP Q16620 EXPRESSION TAG SEQADV 4AT3 MET A 3 UNP Q16620 EXPRESSION TAG SEQRES 1 A 299 GLY ALA MET ASP THR PHE VAL GLN HIS ILE LYS ARG HIS SEQRES 2 A 299 ASN ILE VAL LEU LYS ARG GLU LEU GLY GLU GLY ALA PHE SEQRES 3 A 299 GLY LYS VAL PHE LEU ALA GLU CYS TYR ASN LEU CYS PRO SEQRES 4 A 299 GLU GLN ASP LYS ILE LEU VAL ALA VAL LYS THR LEU LYS SEQRES 5 A 299 ASP ALA SER ASP ASN ALA ARG LYS ASP PHE HIS ARG GLU SEQRES 6 A 299 ALA GLU LEU LEU THR ASN LEU GLN HIS GLU HIS ILE VAL SEQRES 7 A 299 LYS PHE TYR GLY VAL CYS VAL GLU GLY ASP PRO LEU ILE SEQRES 8 A 299 MET VAL PHE GLU TYR MET LYS HIS GLY ASP LEU ASN LYS SEQRES 9 A 299 PHE LEU ARG ALA HIS GLY PRO ASP ALA VAL LEU MET ALA SEQRES 10 A 299 GLU GLY ASN PRO PRO THR GLU LEU THR GLN SER GLN MET SEQRES 11 A 299 LEU HIS ILE ALA GLN GLN ILE ALA ALA GLY MET VAL TYR SEQRES 12 A 299 LEU ALA SER GLN HIS PHE VAL HIS ARG ASP LEU ALA THR SEQRES 13 A 299 ARG ASN CYS LEU VAL GLY GLU ASN LEU LEU VAL LYS ILE SEQRES 14 A 299 GLY ASP PHE GLY MET SER ARG ASP VAL TYR SER THR ASP SEQRES 15 A 299 TYR TYR ARG VAL GLY GLY HIS THR MET LEU PRO ILE ARG SEQRES 16 A 299 TRP MET PRO PRO GLU SER ILE MET TYR ARG LYS PHE THR SEQRES 17 A 299 THR GLU SER ASP VAL TRP SER LEU GLY VAL VAL LEU TRP SEQRES 18 A 299 GLU ILE PHE THR TYR GLY LYS GLN PRO TRP TYR GLN LEU SEQRES 19 A 299 SER ASN ASN GLU VAL ILE GLU CYS ILE THR GLN GLY ARG SEQRES 20 A 299 VAL LEU GLN ARG PRO ARG THR CYS PRO GLN GLU VAL TYR SEQRES 21 A 299 GLU LEU MET LEU GLY CYS TRP GLN ARG GLU PRO HIS MET SEQRES 22 A 299 ARG LYS ASN ILE LYS GLY ILE HIS THR LEU LEU GLN ASN SEQRES 23 A 299 LEU ALA LYS ALA SER PRO VAL TYR LEU ASP ILE LEU GLY HET LTI A1839 24 HETNAM LTI (5Z)-5-(CARBAMOYLIMINO)-3-[(5R)-6,7,8,9-TETRAHYDRO-5H- HETNAM 2 LTI BENZO[7]ANNULEN-5-YLSULFANYL]-2,5-DIHYDROISOTHIAZOLE- HETNAM 3 LTI 4-CARBOXAMIDE FORMUL 2 LTI C16 H18 N4 O2 S2 FORMUL 3 HOH *315(H2 O) HELIX 1 1 GLY A 1 PHE A 545 5 6 HELIX 2 2 LYS A 550 HIS A 552 5 3 HELIX 3 3 SER A 594 LEU A 611 1 18 HELIX 4 4 LEU A 641 HIS A 648 1 8 HELIX 5 5 GLY A 649 MET A 655 1 7 HELIX 6 6 THR A 665 GLN A 686 1 22 HELIX 7 7 ALA A 694 ARG A 696 5 3 HELIX 8 8 GLU A 702 LEU A 704 5 3 HELIX 9 9 GLY A 726 HIS A 728 5 3 HELIX 10 10 PRO A 732 MET A 736 5 5 HELIX 11 11 PRO A 737 ARG A 744 1 8 HELIX 12 12 THR A 747 THR A 764 1 18 HELIX 13 13 SER A 774 GLY A 785 1 12 HELIX 14 14 PRO A 795 TRP A 806 1 12 HELIX 15 15 GLU A 809 ARG A 813 5 5 HELIX 16 16 ASN A 815 SER A 830 1 16 SHEET 1 AA 5 ILE A 554 GLU A 559 0 SHEET 2 AA 5 VAL A 568 CYS A 573 -1 O LEU A 570 N LYS A 557 SHEET 3 AA 5 ILE A 583 LEU A 590 -1 O ILE A 583 N CYS A 573 SHEET 4 AA 5 LEU A 629 GLU A 634 -1 O LEU A 629 N LEU A 590 SHEET 5 AA 5 PHE A 619 CYS A 623 -1 N TYR A 620 O VAL A 632 SHEET 1 AB 3 GLY A 639 ASP A 640 0 SHEET 2 AB 3 CYS A 698 VAL A 700 -1 N VAL A 700 O GLY A 639 SHEET 3 AB 3 VAL A 706 ILE A 708 -1 O LYS A 707 N LEU A 699 SHEET 1 AC 2 TYR A 723 VAL A 725 0 SHEET 2 AC 2 THR A 729 LEU A 731 -1 O THR A 729 N VAL A 725 CISPEP 1 GLU A 562 GLY A 563 0 -2.72 CISPEP 2 ASP A 627 PRO A 628 0 2.89 SITE 1 AC1 14 PHE A 565 ALA A 586 PHE A 633 GLU A 634 SITE 2 AC1 14 TYR A 635 MET A 636 LYS A 637 GLY A 639 SITE 3 AC1 14 ASN A 697 LEU A 699 GLY A 709 ASP A 710 SITE 4 AC1 14 HOH A2024 HOH A2079 CRYST1 86.331 94.340 46.037 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011583 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010600 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021722 0.00000